Jennifer Dumbleton

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Isla S. Mackenzie, Ian Ford, George Nuki et al. · The Lancet · 2020 · 342 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

Isla S. Mackenzie, Christopher J. Hawkey, Ian Ford et al. · The Lancet · 2022 · 157 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +16

Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial

C J Hawkey, Anthony Avery, Carol Coupland et al. · The Lancet · 2022 · 68 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care

Jennifer Dumbleton, Anthony Avery, Carol Coupland et al. · EBioMedicine · 2015 · 36 citations · Full text

Pharmacy, Pharmacoeconomics, Preventive Medicine +14

Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

Hugh Gallagher, Jennifer Dumbleton, Tom Maishman et al. · Trials · 2022 · 25 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12